TickerGuard
Buy Day today: Neutral (59) Mixed market breadth · major macro event coming up
TEVA

Teva Pharma Industries Ltd

Healthcare · Drug Manufacturers - Specialty & Generic

36.50$ -0.6% vs. previous close Closing price · As of: Aug 13, 2026

Statements

Cash Flow

Teva Pharma Industries Ltd (TEVA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at 1,649 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow TEVA
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
5,127 5,542 5,225 3,507 2,446 538 1,216 798 1,590 1,368 1,247 1,649
1,508 1,308 1,524 2,112 1,842 416 1,557 1,330 1,308 1,153 1,059 1,002
95 117 124 133 155 20 129 119 124 121 123 157
274 1,679 2,153 21,015 5,776 1,925 6,855 729 1,378
290 967 1,219 -363 -1,823 -112 -2,188 -1,701 1,355 -72 -435 -1,366
929 772 901 874 651 119 578 562 548 526 498 501
-1,450 -5,565 -35,740 2,164 1,866 1,355 863 1,523 656 968 792 737
1,156 1,155 1,558 1,161 22 52
-500 -439 27,614 0.0 -1,782 -1,975
-1,224 -393 26,251 -4,983 -3,272 -1,863 -1,880 -1,675 -1,369 -1,701 -1,641 -1,814
-2,375 4,805 25,217 -5,750 -3,351 -241 -1,885 -2,172 -1,487 -1,913 -1,791 -2,151
1,188 4,720 -5,958 -25 819 734 202 21 636 393 73 256
4,198 4,770 4,324 2,633 1,795 419 638 236 1,042 842 749 1,148

Data as of: August 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?